Skip to main content
. 2019 Feb 6;7:e6375. doi: 10.7717/peerj.6375

Figure 9. Survival analysis of CD5L and CSMD1 in all the HCC patients from TCGA database through GEPIA.

Figure 9

(A) HCC patients high CD5L expression have a better overall survival than those with low expression; (B) HCC patients high CSMD1 expression have a worse disease-free survival than those with low expression. The median expression of CD5L and CSMD1 was set as the threshold for splitting the high-expression and low-expression cohorts. Log Rank (Mantel–Cox) was used and p < 0.05 was considered to be statistically significant.